Phase I Clinical Trial of TQC2731 Injection

Clinical trial NCT04923607 · UNKNOWN

Trial details

NCT number: NCT04923607
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Severe Persistent Controlled

Start date: 2021-06-25
Primary completion: 2023-08-25
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.